<DOC>
	<DOCNO>NCT01139216</DOCNO>
	<brief_summary>The purpose study ass dose-related effect TU-100 , botanical agent modulate gastrointestinal nerve , rectal compliance , rectal sensation threshold small bowel colonic transit female patient functional constipation compare placebo .</brief_summary>
	<brief_title>Effect TU-100 Rectal Compliance , Rectal Sensation Small Bowel Colonic Transit Females With Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>1 . Meet Rome III criterion functional constipation 2 . Willing able provide write informed consent 3 . Females , pregnant breastfeeding Females childbearing potential must use acceptable form contraception study 30 day last dose . Acceptable method include surgical sterilization , hormonal contraceptive ( oral contraceptive , DepoProvera , Nuva Ring , condom use spermicide , IUD abstinence . Females consider childbearing potential postmenopausal least two year surgically sterilize . 4 . Ages 18 65 year old inclusive 5 . A body mass index ( BMI ) 18 40 kg/m2 inclusive 6 . A negative urine drug screen Visit 1 7 . Normal clinically significant laboratory result review study physician 8 . A normal rectal exam result file within past 2 year perform Visit 1 order exclude possibility evacuation disorder . Examination must exclude finding suggestive evacuation disorder high sphincter tone rest , failure perineal descent spasm , tenderness paradoxical contraction puborectalis muscle . 9 . Do sufficient criterion irritable bowel syndrome ( IBS ) 1 . Structural metabolic diseases/conditions affect gastrointestinal system functional gastrointestinal disorder constipation . 2 . Taking medication opinion principal investigator potential alter GI transit . This include limited osmotic stimulant laxative , magnesium aluminumcontaining antacid , prokinetics , erythromycin , narcotic , anticholinergic , selective norepinephrine reuptake inhibitor ( SNRIs ) , opiates , GABAergic agents benzodiazepine . Note : Tricyclic antidepressant permissible dos equal less 25 mg daily ; selective serotonin reuptake inhibitor ( SSRI ) antidepressants permissible low , stable dos . Analgesics Tylenol , ibuprofen , naproxen aspirin permissible . All medication shall review principal investigator case case basis . Rescue medication : Rescue medication shall review approve necessary exacerbation constipation study medication treatment period lengthy , 28 day total . The patient contact study staff request review approval use rescue medication principal investigator . The use rescue medication document patient bowel pattern diary . Rescue medication allow within 7 day abbreviate baseline full transit scintigraphy ensure data integrity . 3 . Clinical evidence , include limit clinically significant abnormal physical exam laboratory test result past event document past medical record , current clinically significant abnormal physical exam laboratory test result could indicate significant cardiovascular , respiratory , renal , hepatic , gastrointestinal , hematological , neurological , psychiatric disease interfere objective study . If laboratory test result abnormal clinically significant , may repeat discretion principal investigator . If laboratory test result remain abnormal clinically significant , patient discontinue study refer primary care physician evaluation . 4 . Patients consider alcoholic remission know substance abuser . 5 . Patients participate another clinical study past 30 day . 6 . Patients history allergic reaction egg , ginseng , ginger Sichuan pepper 7 . Patients clinically lactose intolerant 8 . Patients must agree avoid alcohol day Visits 5 , 6 7 avoid corrupt data anorectal manometry rectal barostat test .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Digestive system disease</keyword>
	<keyword>Gastrointestinal disease</keyword>
	<keyword>Intestinal disease</keyword>
	<keyword>Colonic inertia</keyword>
</DOC>